N1174: Phase I/Comparative Randomized Phase II Trial of TRC105 Plus Bevacizumab Versus Bevacizumab in Bevacizumab-Na?ve Patients With Recurrent Glioblastoma Multiforme
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to compare and good and bad effects of using a combination of the chemotherapy drug, TRC105, with the usual approach chemotherapy drug bevacizumab to using the usual approach bevacizumab drug alone.
Description
The aims of this study are to assess the safety and adverse events of TRC105 in combination with bevacizumab and to determine the efficacy of TRC105 in combination with bevacizumab in recurrent glioblastoma as measured by progression-free survival and compare it with the efficacy of bevacizumab alone.
Details
| Condition | glioblastoma |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX4193 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.